Next Article in Journal
The Prognostic Impact of Additional Molecular and Cytogenetic Abnormalities on AML Patients with NPM1- and/or FLT3-ITD Mutations Receiving Intensive Chemotherapy: Real-World Data from the Greek Registry
Previous Article in Journal
Real-World Evidence of Bevacizumab and Panitumumab Drug Resistance and Drug Ineffectiveness from EudraVigilance Database
 
 
Article

Article Versions Notes

Cancers 2025, 17(4), 666; https://doi.org/10.3390/cancers17040666
Action Date Notes Link
article html file updated 30 August 2026 22:21 CEST Update https://www.mdpi.com/2072-6694/17/4/666/html
article html file updated 24 June 2025 16:40 CEST Update -
article html file updated 17 February 2025 10:47 CET Update -
article pdf uploaded. 17 February 2025 10:46 CET Updated version of record https://www.mdpi.com/2072-6694/17/4/666/pdf
article xml uploaded. 17 February 2025 10:46 CET Update https://www.mdpi.com/2072-6694/17/4/666/xml
article xml file uploaded 17 February 2025 10:46 CET Update -
article html file updated 16 February 2025 10:17 CET Original file -
article pdf uploaded. 16 February 2025 10:16 CET Version of Record https://www.mdpi.com/2072-6694/17/4/666/pdf-vor
article xml uploaded. 16 February 2025 10:16 CET Update -
article xml file uploaded 16 February 2025 10:16 CET Original file -
Back to TopTop